Genetic basis of mitochondrial optic neuropathies

Current Molecular Medicine

Volumn 14, Issue 8, 2014, Pages 985-992

  Maresca, A ^a,b   Caporali, L ^a,b   Strobbe, D ^a,b   Zanna, C ^a,b   Malavolta, D ^a,b   La Morgia, C ^a,b   Valentino, M L ^a,b   Carelli, V ^a,b  

^a BELLARIA HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

DOA; Environmental triggers; Genetic modifiers; LHON; Mitochondrial biogenesis; Mitochondrial DNA; OPA1; Optic neuropathies

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MITOCHONDRIAL OPTIC NEUROPATHY; OPTIC NERVE ATROPHY; OPTIC NERVE DISEASE; PENETRANCE; PROTEIN EXPRESSION; SEX DIFFERENCE;

EID: 84911476001     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524014666141010132627     Document Type: Article

References (113)

1. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 2004; 23: 53-89.
2. Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies-disease mechanisms and therapeutic strategies. Prog Retin Eye Res 2011; 30: 81-114.
3. Sadun AA, La Morgia C, Carelli V. Mitochondrial optic neuropathies: our travels from bench to bedside and back again. Clin Experiment Ophthalmol 2013; 41: 702-712.
4. Sadun AA, Win PH, Ross-Cisneros FN, Walker SO, Carelli V. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc 2000; 98: 223-232; discussion 232-235.
5. Pan BX, Ross-Cisneros FN, Carelli V, et al. Mathematically modeling the involvement of axons in Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2012; 53: 7608-7617.
6. Leber T. Uber hereditare und congenital-angelegte Sehnervenleiden. Archiv fur Ophthalmologie 1871; 17: 249-291.
7. Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Scand 1959; 37: 1-146.
8. Maresca A, la Morgia C, Caporali L, Valentino ML, Carelli V. The optic nerve: a "mito-window" on mitochondrial neurodegeneration. Mol Cell Neurosci 2013; 55: 62-76.
9. Carelli V, La Morgia C, Valentino ML, et al. Idebenone treatment in Leber's hereditary optic neuropathy. Brain 2011; 134: e188.
10. Barboni P, Valentino ML, La Morgia C, et al. Idebenone treatment in patients with OPA1-mutant dominant optic atrophy. Brain 2013; 136: e231.
11. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 2002; 40: 573-584.
12. Giles RE, Blanc H, Cann HM, Wallace DC. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci U S A 1980; 77: 6715-6719.
13. Erickson RP. Leber's optic atrophy, a possible example of maternal inheritance. Am J Hum Genet 1972; 24: 348-349.
14. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-1430.
15. Ruiz-Pesini E, Lott MT, Procaccio V, et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 2007; 35: D823-D828. URL: http://www. mitomap. org.
16. Koopman WJ, Nijtmans LG, Dieteren CE, et al. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal 2010; 12: 1431-1470.
17. Montoya J, López-Gallardo E, Díez-Sánchez C, López-Pérez MJ, Ruiz-Pesini E. 20 years of human mtDNA pathologic point mutations: carefully reading the pathogenicity criteria. Biochim Biophys Acta 2009; 1787: 476-483.
18. Achilli A, Iommarini L, Olivieri A, et al. Rare primary mitochondrial DNA mutations and probable synergistic variants in Leber's hereditary optic neuropathy. PLoS One 2012; 7: e42242.
19. Carelli V, Giordano C, d'Amati G. Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet 2003; 19: 257-262.
20. Alexander C, Votruba M, Pesch UEA, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to choromosome 3q28. Nat Genet 2000; 26: 211-215.
21. Delettre C, Lenaers G, Griffoin J-M, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000; 26: 207-210.
22. Lenaers G, Hamel C, Delettre C, et al. Dominant optic atrophy. Orphanet J Rare Dis 2012; 7: 46.
23. Ferré M, Amati-Bonneau P, Tourmen Y, Malthièry Y, Reynier P. eOPA1: an online database for OPA1 mutations. Hum Mutat 2005; 25: 423-428. http://mitolab. eu/eopa1-moved-to-mitodyn.
24. Reynier P, Amati-Bonneau P, Verny C, et al. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet 2004; 41: e110.
25. Rendtorff ND, Lodahl M, Boulahbel H, et al. Identification of p. A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment. Am J Med Genet A 2011; 155A: 1298-1313.
26. Huizing M, Dorward H, Ly L, et al. OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria. Mol Genet Metab 2010; 100: 149-154.
27. Ryu SW, Jeong HJ, Choi M, Karbowski M, Choi C. Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation. Cell Mol Life Sci 2010; 67: 2839-2850.
28. Raturi A, Simmen T. Where the endoplasmic reticulum and the mitochondrion tie the knot: the mitochondria-associated membrane (MAM). Biochim Biophys Acta 2013; 1833: 213-224.
29. Ross-Cisneros FN, Pan BX, Silva RA, et al. Optic nerve histopathology in a case of Wolfram Syndrome: A mitochondrial pattern of axonal loss. Mitochondrion 2013; 13: 841-845.
30. Hanein S, Garcia M, Fares-Taie L, et al. TMEM126A is a mitochondrial located mRNA (MLR) protein of the mitochondrial inner membrane. Biochim Biophys Acta 2013; 1830: 3719-3733.
31. Howell N, Mackey DA. Low-penetrance branches in matrilineal pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 1998; 63: 1220-1224.
32. Brown MD, Voljavec AS, Lott MT, Torroni A, Yang CC, Wallace DC. Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics 1992; 130: 163-173.
33. Wallace DC, Brown MD, Lott MT. Mitochondrial DNA variation in human evolution and disease. Gene 1999; 238: 211-230.
34. Torroni A, Petrozzi M, D'Urbano L, et al. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet 1997; 60: 1107-1121.
35. Carelli V, Achilli A, Valentino ML, et al. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am J Hum Genet 2006; 78: 564-574.
36. Hudson G, Carelli V, Spruijt L, et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 2007; 81: 228-233.
37. Brown MD, Sun F, Wallace DC. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 1997; 60: 381-387.
38. Lamminen T, Huoponen K, Sistonen P, et al. mtDNA haplotype analysis in Finnish families with Leber hereditary optic neuropathy. Eur J Hum Genet 1997; 5: 271-279.
39. Hofmann S, Jaksch M, Bezold R, et al. Population genetics and disease susceptibility: characterization of central European haplogroups by mtDNA gene mutations, correlation with D loop variants and association with disease. Hum Mol Genet 1997; 6: 1835-1846.
40. Ji Y, Zhang AM, Jia X, et al. Mitochondrial DNA haplogroups M7b1'2 and M8a affect clinical expression of Leber hereditary optic neuropathy in Chinese families with the m. 11778G-->a mutation. Am J Hum Genet 2008; 83: 760-768.
41. Yu D, Jia X, Zhang AM, et al. Mitochondrial DNA sequence variation and haplogroup distribution in Chinese patients with LHON and m. 14484T>C. PLoS One 2010; 5: e13426.
42. Moreno-Loshuertos R, Acin-Perez R, Fernandez-Silva P, et al. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DnA variants. Nat Genet 2006; 38: 1261-1268.
43. Pello R, Martín MA, Carelli V, et al. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum Mol Genet 2008; 17: 4001-4011.
44. Gómez-Durán A, Pacheu-Grau D, Martínez-Romero I, et al. Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy. Biochim Biophys Acta 2012; 1822: 1216-1222.
45. Tsao K, Aitken PA, Johns DR. Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy. Br J Ophthalmol 1999; 83: 577-581.
46. Sadun AA, Carelli V, Salomao SR, et al. Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 2003; 136: 231-238.
47. Kirkman MA, Yu-Wai-Man P, Korsten A, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009; 132: 2317-2326.
48. Carelli V, Franceschini F, Venturi S, et al. Grand rounds: could occupational exposure to n-hexane and other solvents precipitate visual failure in leber hereditary optic neuropathy? Environ Health Perspect 2007; 115: 113-115.
49. Ghelli A, Porcelli AM, Zanna C, et al. The background of mitochondrial DNA haplogroup J increases the sensitivity of Leber's hereditary optic neuropathy cells to 2, 5-hexanedione toxicity. PLoS One 2009; 4: e7922.
50. Kayser EB, Hoppel CL, Morgan PG, Sedensky MM. A mutation in mitochondrial complex I increases ethanol sensitivity in Caenorhabditis elegans. Alcohol Clin Exp Res 2003; 27: 584-592.
51. Dotti MT, Plewnia K, Cardaioli E, et al. A case of ethambutol-induced optic neuropathy harbouring the primary mitochondrial LHON mutation at nt 11778. J Neurol 1998; 245: 302-303.
52. De Marinis M. Optic neuropathy after treatment with anti-tubercolous drugs in a subject with Leber's hereditary optic neuropathy mutation. J Neurol 2001; 248: 818-819.
53. Luca CC, Lam BL, Moraes CT. Erythromycin as a potential precipitating agent in the onset of Leber's hereditary optic neuropathy. Mitochondrion 2004; 4: 31-46.
54. Mackey Da, Fingert JH, Luzhansky JZ, et al. Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus. Eye 2003; 17: 312-317.
55. Pacheu-Grau D, Gómez-Durán A, López-Pérez MJ, Montoya J, Ruiz-Pesini E. Mitochondrial pharmacogenomics: barcode for antibiotic therapy. Drug Discov Today 2010; 15: 33-39.
56. Pacheu-Grau D, Gómez-Durán A, Iglesias E, López-Gallardo E, Montoya J, Ruiz-Pesini E. Mitochondrial antibiograms in personalized medicine. Hum Mol Genet 2013; 22: 1132-1139.
57. Man PY, Brown DT, Wehnert MS, et al. NDUFA-1 is not a nuclear modifier gene in Leber hereditary optic neuropathy. Neurology 2002; 58: 1861-1862.
58. Petruzzella V, Tessa A, Torraco A, et al. The NDUFB11 gene is not a modifier in Leber hereditary optic neuropathy. Biochem Biophys Res Commun 2007; 355: 181-187.
59. Chalmers RM, Bandmann O, Harding AE. Debrisoquine hydroxylase polymorphism in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1996; 60: 588.
60. Man PY, Morris CM, Zeviani M, Carrara F, Turnbull DM, Chinnery PF. The role of APOE in the phenotypic expression of Leber hereditary optic neuropathy. J Med Genet 2003; 40: e41.
61. Hudson G, Yu-Wai-Man P, Zeviani M, Chinnery PF. Genetic variation in the methylenetetrahydrofolate reductase gene, MTHFR, does not alter the risk of visual failure in Leber's hereditary optic neuropathy. Mol Vis 2009; 15: 870-875.
62. Hudson G, Yu-Wai-Man P, Griffiths PG, et al. Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON. Mitochondrion 2011; 11: 620-622.
63. Hudson G, Yu-Wai-Man P, Griffiths PG, et al. Variation in OPA1 does not explain the incomplete penetrance of Leber hereditary optic neuropathy. Mol Vis 2010; 16: 2760-2764.
64. Ishikawa K, Funayama T, Ohde H, Inagaki Y, Mashima Y. Genetic variants of TP53 and EPHX1 in Leber's hereditary optic neuropathy and their relationship to age at onset. Jpn J Ophthalmol 2005; 49: 121-126.
65. Phasukkijwatana N, Kunhapan B, Stankovich J, et al. Genome-wide linkage scan and association study of PARL to the expression of LHON families in Thailand. Hum Genet 2010; 128: 39-49.
66. Zhang AM, Jia X, Zhang Q, Yao YG. No association between the SNPs (rs3749446 and rs1402000) in the PARL gene and LHON in Chinese patients with m. 11778G>A. Hum Genet 2010; 128: 465-468.
67. Giordano C, Iommarini L, Giordano L, et al. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy. Brain 2014; 137: 335-353.
68. Ramos Cdo V, Bellusci C, Savini G, et al. Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2009; 50: 1666-1674.
69. Burde RM. Optic disk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993; 116: 759-764.
70. Macgregor S, Hewitt AW, Hysi PG, et al. Genome-wide association identifies ATOH7 as a major gene determining human optic disc size. Hum Mol Genet 2010; 19: 2716-2724.
71. Toomes C, Marchbank NJ, Mackey DA, et al. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet 2001; 10: 1369-1378.
72. Cohn AC, Toomes C, Potter C, et al. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am J Ophthalmol 2007; 143: 656-662.
73. Huang T, Whang JD, Kimonis V. Sex-influenced autosomal dominant optic atrophy is caused by mutations of IVS9 +2A>G in the OPA1 gene. Genet Med 2006; 8: 59.
74. Gorgone G, Li Volti S, Cavallaro N, Conti L, Profeta GM, Mollica F. Familial optic atrophy with sex-influenced severity. A new variety of autosomal-dominant optic atrophy? Ophthalmologica 1986; 192: 28-33.
75. Pierron D, Ferré M, Rocher C, et al. OPA1-related dominant optic atrophy is not strongly influenced by mitochondrial DNA background. BMC Med Genet 2009; 10: 70.
76. Han J, Thompson-Lowrey AJ, Reiss A, et al. OPA1 mutations and mitochondrial DNA haplotypes in autosomal dominant optic atrophy. Genet Med 2006; 8: 217-225.
77. Craig JE, Hewitt AW, Dimasi DP, et al. The role of the Met98Lys optineurin variant in inherited optic nerve diseases. Br J Ophthalmol 2006; 90: 1420-1424.
78. Barboni P, Carbonelli M, Savini G, et al. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size. Ophthalmology 2010; 117: 1547-1553.
79. Carelli V, La Morgia C, Valentino ML, Barboni P, Ross-Cisneros FN, Sadun AA. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. Biochim Biophys Acta 2009; 1787: 518-528.
80. Carelli V, Valentino ML, Liguori R, et al. Leber's hereditary optic neuropathy (LHON/11778) with myoclonus: report of two cases. J Neurol Neurosurg Psychiatry 2001; 71: 813-816.
81. La Morgia C, Achilli A, Iommarini L, et al. Rare mtDNA variants in Leber hereditary optic neuropathy families with recurrence of myoclonus. Neurology 2008; 70: 762-770.
82. Funalot B, Reynier P, Vighetto A, et al. Leigh-like encephalopathy complicating Leber's hereditary optic neuropathy. Ann Neurol 2002; 52: 374-347.
83. Fruhman G, Landsverk ML, Lotze TE, et al. Atypical presentation of Leigh syndrome associated with a Leber hereditary optic neuropathy primary mitochondrial DNA mutation. Mol Genet Metab 2011; 103: 153-160.
84. Grazina MM, Diogo LM, Garcia PC, et al. Atypical presentation of Leber's hereditary optic neuropathy associated to mtDNA 11778G>A point mutation--A case report. Eur J Paediatr Neurol 2007; 11: 115-118.
85. Vetrugno R, Valentino ML, La Morgia C, et al. Sleep-related periodic respiration with central sleep apnea in Leber Hereditary Optic Neuropathy (LHON). Sleep Med 2010; 11: 426-427.
86. Harding AE, Sweeney MG, Miller DH, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992; 115: 979-989.
87. Nikoskelainen EK, Marttila RJ, Huoponen K, et al. Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995; 59: 160-164.
88. Gilhuis HJ, Schelhaas HJ, Cruysberg JR, Zwarts MJ. Demyelinating polyneuropathy in Leber hereditary optic neuropathy. Neuromuscul Disord 2006; 16: 394-395.
89. Mnatsakanyan L, Ross-Cisneros FN, Carelli V, Wang MY, Sadun AA. Axonal degeneration in peripheral nerves in a case of Leber hereditary optic neuropathy. J Neuroophthalmol 2011; 31: 6-11.
90. Nikoskelainen EK, Savontaus ML, Huoponen K, Antila K, Hartiala J. Pre-excitation syndrome in Leber's hereditary optic neuropathy. Lancet 1994; 344: 857-858.
91. Mashima Y, Kigasawa K, Hasegawa H, Tani M, Oguchi Y. High incidence of pre-excitation syndrome in Japanese families with Leber's hereditary optic neuropathy. Clin Genet 1996; 50: 535-537.
92. Yang J, Zhu Y, Chen L, et al. Novel A14841G mutation is associated with high penetrance of LHON/C4171A family. Biochem Biophys Res Commun 2009; 386: 693-696.
93. Yang J, Zhu Y, Tong Y, et al. The novel G10680A mutation is associated with complete penetrance of the LHON/T14484C family. Mitochondrion 2009; 9: 273-278.
94. Brown MD, Allen JC, Van Stavern GP, Newman NJ, Wallace DC. Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the 11778 and 14484 primary mutations. Am J Med Genet 2001; 104: 331-228.
95. Howell N, Miller NR, Mackey DA, et al. Lightning strikes twice: Leber hereditary optic neuropathy families with two pathogenic mtDNA mutations. J Neuroophthalmol 2002; 22: 262-269.
96. Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008; 131: 338-351.
97. Hudson G, Amati-Bonneau P, Blakely EL, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008; 131: 329-337.
98. Yu-Wai-Man P, Griffiths PG, Gorman GS, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010; 133: 771-786.
99. Elachouri G, Vidoni S, Zanna C, et al. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res 2011; 21: 12-20.
100. Bu XD, Rotter JI. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci U S A 1991; 88: 8198-8202.
101. Bu X, Rotter JI. Leber hereditary optic neuropathy: estimation of number of embryonic precursor cells and disease threshold in heterozygous affected females at the X-linked locus. Clin Genet 1992; 42: 143-148.
102. Pegoraro E, Carelli V, Zeviani M, et al. X-inactivation pattern in female LHON (Leber's hereditary optic neuropathy) patients do not support a strong X-linked determinant. Am J Med Genet 1996; 61: 356-362.
103. Oostra RJ, Kemp S, Bolhuis PA, Bleeker-Wagemakers EM. No evidence for "skewed" inactivation of the X chromosome as cause of Leber's hereditary optic neuropathy in female carriers. Hum Genet 1996; 97: 500-505.
104. Pegoraro E, Vettori A, Valentino ML, et al. X-inactivation pattern in multiple tissues from two Leber's hereditary optic neuropathy (LHON) patients. Am J Med Genet 2003; 119: 37-40.
105. Hudson G, Keers S, Yu Wai Man P, et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet 2005; 77: 1086-1091.
106. Shankar SP, Fingert JH, Carelli V, et al. Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy. Ophthalmic Genet 2008; 29: 17-24.
107. Ji Y, Jia X, Li S, Xiao X, Guo X, Zhang Q. Evaluation of the X-linked modifier loci for Leber hereditary optic neuropathy with the G11778A mutation in Chinese. Mol Vis 2010; 16: 416-424.
108. Carelli V. Leber's hereditary optic neuropathy. In: Schapira, A. H. V., DiMauro, S., ed. Mitochondrial Disorders in Neurology, 2nd Ed. Boston: Butterworth-Heinemann. 2002; 115-142.
109. Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003; 34: 546-552.
110. Vina J, Sastre J, Pallardo' FV, Gambini J, Borra's C. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res 2006; 40: 1359-1365.
111. Chen JQ, Cammarata PR, Baines CP, Yager JD. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological pathological and pharmacological implications. Biochim Biophys Acta 2009; 1793: 1540-1570.
112. Giordano C, Montopoli M, Perli E, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain 2011; 134: 220-234.
113. Dimauro S, Schon EA, Carelli V, Hirano M. The clinical maze of mitochondrial neurology. Nat Rev Neurol 2013; 9: 429-444.